MUMBAI, India, July 5 -- Intellectual Property India has published a patent application (202517056872 A) filed by Eli Lilly And Company, Indianapolis, on June 13, for 'rnai agent with modified nucleotides.'
Inventor(s) include Chauvigne-Hines, Lacie Marie; Fritschi, Sarah Katharina; Gonzalez-Valcarcel, Isabel Cristina; Greene, Erica Theresa; Keel, Katarina Lynn; Perkins, Douglas Raymond; Wrobleski, Aaron David; York, Jeremy S.; Miller, Daniel Keith; Herron, Shawn; Hurdle, Carolyn M.; and Liu, Feng.
The application for the patent was published on July 4, under issue no. 27/2025.
According to the abstract released by the Intellectual Property India: "Provided herein are novel compounds and RNAi agents comprising modified nucleotides, compositions comprising such compounds or RNAi agents, and methods of using such compounds or RNAi agents."
The patent application was internationally filed on Dec. 12, 2023, under International application No.PCT/US2023/083651.
Disclaimer: Curated by HT Syndication.
